• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Neurotech International

Neurotech International

ASX:NTI

  • Home
  • Corporate
    • Board and Management
    • Corporate Directory
    • Corporate Governance
    • Corporate Videos
  • Development Programs
    • Biopharmaceutical Trials
    • Group Strategy and Target Markets
    • NTI164
    • Clinical Trials
    • Pathways to Commercialisation
  • Investors
    • Investor Dashboard
    • ASX Announcements
    • Investor Conference Calls  
    • Company Reports
    • Presentations
    • Research
    • News & Media
    • Fact Sheets
    • Analyst Reports
    • Right to Receive Documents
  • Contact

News &
Media

  • South West Connect Conference Presentation: Video

    24 October 2022
    South West Connect

    Executive Director, Dr Tom Duthy presents Neurotech International at the South West Connect Conference on the 21st October, 2022. Watch the video recording here.

    View More: South West Connect Conference Presentation: Video
  • Neurotech International is anticipating results from its extended world first study of a medicinal cannabis product in children which could be a game-changer in autism treatment.

    21 September 2022
    Stockhead

    Neurotech is anticipating results from its extended world first study of a medicinal cannabis product in children which could be a game-changer in autism treatment. Read the full story here.

    View More: Neurotech International is anticipating results from its extended world first study of a medicinal cannabis product in children which could be a game-changer in autism treatment.
  • ASX Small & Mid-Cap Conference: Neurotech International Limited

    20 September 2022
    ASX

    Executive Director, Dr Tom Duthy presents Neurotech International at the ASX Small and Mid-Cap Conference on the 14th September, 2022. Watch the video recording here.

    View More: ASX Small & Mid-Cap Conference: Neurotech International Limited
  • Neurotech International with Proactive at the ASX Small and Mid-Cap Conference

    19 September 2022
    Proactive Investors

    Neurotech International Executive Director Dr Tom Duthy speaks with Proactive at the ASX Small and Mid-Cap Conference September 2022.

    View More: Neurotech International with Proactive at the ASX Small and Mid-Cap Conference
  • Cannabis extract has Autism success

    3 September 2022
    The Post

    View More: Cannabis extract has Autism success
  • New Hope for Children Living with Autism. Channel 7 NEWS 28 August 2022

    28 August 2022
    Stocks Down Under
    View More: New Hope for Children Living with Autism. Channel 7 NEWS 28 August 2022
  • Neurotech International appoints industry expert during key phase of growth

    18 August 2022
    Stockhead

    Neurotech International has made key appointments and changes to its board as it focuses on its developing and commercialising neurological solutions, including a cannabis breakthrough for paediatric autism.

    View More: Neurotech International appoints industry expert during key phase of growth
  • Gerald Quigley, short discussion on 4RO Rockhampton regarding Autism

    2 August 2022
    4RO
    View More: Gerald Quigley, short discussion on 4RO Rockhampton regarding Autism
  • Gerald Quigley, Co-host of The House of Wellness on 6PR discusses exciting new developments in Autism Spectrum Disorder (ASD) field linked to Cannabis, including a particular extract called NTI164.

    30 July 2022
    6PR
    View More: Gerald Quigley, Co-host of The House of Wellness on 6PR discusses exciting new developments in Autism Spectrum Disorder (ASD) field linked to Cannabis, including a particular extract called NTI164.
Previous
1 … 4 5 6 7 8 9
Next

Footer

Suite 102 / Level 1, 55 Collins Street
Melbourne VIC 3000
Australia

moc.l1762498184anoit1762498184anret1762498184nihce1762498184torue1762498184n@ofn1762498184i1762498184

+61 (3) 9498 3132

Subscribe to our latest announcements

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.

Copyright © 2025 Neurotech International • Site by White Noise Communications

Download prospectus